MEI Pharma Inc.

NASDAQ: MEIP · Real-Time Price · USD
4.66
0.07 (1.53%)
At close: Aug 20, 2025, 3:59 PM

MEI Pharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
-31.66M -38.22M -46.6M 17.78M 26.16M 19.84M 41.16M -31.84M -37.87M -43.18M -59.2M -54.45M -44.11M -54.67M -60.36M -50.58M -63.34M -36.35M -45.11M
Depreciation & Amortization
493K 579K 664K 383K 356K 367K 374K 386K 373K 365K 348K 326K 311K 294K 293K 285K 234K 192K 147K
Stock-Based Compensation
175K 827K 1.78M 2.28M 2.18M 2.43M 2.39M 3.59M 3.94M 5.86M 7.37M 8.35M 9.75M 9.56M 9.84M 10.24M 9.56M 8.47M 7.63M
Other Working Capital
-12.36M -6.32M -10.07M -81.13M -72.55M -74.91M -96.38M -24.59M -20.98M -10.64M 2.23M 17.99M 17.5M 9.5M 38.09M 22.29M 77.54M 74.83M 53.87M
Other Non-Cash Items
6.96M 7.3M 15.32M 12.55M 686K 1.91M -1.46M 1.44M 1.42M -12.03M -16.91M -19.84M -27.97M -15.17M -9.94M -7.09M 32.36M 24.41M 32.63M
Deferred Income Tax
n/a n/a -2.85M 66K 66K 66K 2.92M n/a n/a n/a n/a n/a n/a 9.27M 2.19M -11.04M -11.04M -20.31M -13.22M
Change in Working Capital
-12.34M -7.28M -12.49M -84.28M -73.97M -77.59M -101.59M -24.95M -23.43M -11.41M 13.7M 16.88M 17.52M 7.53M 27.41M 26.2M 80.62M 77.34M 57.15M
Operating Cash Flow
-36.38M -36.04M -43.43M -50.47M -43.78M -52.98M -56.19M -52.48M -56.69M -61.51M -55.81M -48.75M -44.5M -43.19M -30.57M -31.96M 48.41M 53.76M 39.23M
Capital Expenditures
n/a n/a -7K n/a 28K 35K 105K 35K -299K -420K -534K -479K -181K -67K -72K -708K -809K -1.59M -1.53M
Cash Acquisitions
n/a n/a -24.52M -24.52M -24.55M -24.56M -22K -22K -20.41M -20.41M -20.42M -20.42M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a -24.29M -34.03M -58.23M -67.9M -67.84M -91.91M -101.76M -146.59M -167.21M -246.71M -272.65M -313.15M -378.28M -425.16M -420.15M -425.12M -335.26M -225.29M
Sales Maturities Of Investments
54.18M 78.6M 92.91M 107.38M 116.94M 126.79M 136.79M 155.49M 201.29M 227.16M 252.88M 280.02M 310.1M 375.34M 460.45M 445.57M 355.6M 260.23M 120.04M
Other Investing Acitivies
-24.01M -23.89M 139K 122K 24.6M 24.47M 10.42M 24.22M 44.68M 44.69M 34.22M 20.42M n/a n/a n/a n/a n/a n/a -5K
Investing Cash Flow
54.69M 54.82M 58.88M 49.14M 48.99M 58.9M 44.91M 53.69M 54.41M 59.54M 5.63M 6.89M -3.23M -3M 35.23M 24.71M -70.33M -76.61M -106.78M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a -40K -40K -40K -40K n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a -11.66M -23.32M -23.32M -23.32M -11.66M n/a n/a n/a -60K -60K -60K -60K n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-208K 11.45M 11.45M 11.45M 11.62M -40K -40K -80K -20K 400K -3.06M -3.21M -3.17M -3.46M -50K 268K 401K 275K 324K
Financial Cash Flow
-208K -208K -11.87M -11.87M -11.66M -11.66M n/a -40K -20K 340K 49.2M 49.05M 49.1M 48.86M 14K 3.47M 24.23M 24.1M 72.53M
Net Cash Flow
18.1M 18.57M 3.58M -13.2M -6.44M -5.74M -11.28M 1.17M -2.3M -1.63M -968K 7.2M 1.37M 2.67M 4.67M -3.79M 2.31M 1.24M 4.97M
Free Cash Flow
-36.38M -36.04M -43.44M -50.47M -43.75M -52.94M -56.09M -52.45M -56.98M -61.93M -56.34M -49.23M -44.68M -43.26M -30.65M -32.67M 47.6M 52.17M 37.69M